Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).
They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy. PARP inhibitors appear to improve progression-free survival in women with recurrent platinum-sensitive ovarian cancer, as evidenced mainly by olaparib added to conventional treatment.
PARP (Poly ADP-Ribose Polymerase) Inhibitor first approval in United States in 2014. And in the last several years, global market (value) of PARP (Poly ADP-Ribose Polymerase) Inhibitor developed rapidly, with an average growth rate of 133.8% during 2015 to 2018.
Market Analysis and Insights: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market is valued at US$ 2178 million in 2019. The market size will reach US$ 16180 million by the end of 2026, growing at a CAGR of 32.8% during 2021-2026.
Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Scope and Market Size
PARP (Poly ADP-Ribose Polymerase) Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Lynparza
Zejula
Rubraca
Talzenna
Other
Segment by Application
Ovarian Cancer
Breast Cancer
Other
By Company
AstraZeneca
Tesaro
Merck & Co
Clovis Oncology
Pfizer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy. PARP inhibitors appear to improve progression-free survival in women with recurrent platinum-sensitive ovarian cancer, as evidenced mainly by olaparib added to conventional treatment.
PARP (Poly ADP-Ribose Polymerase) Inhibitor first approval in United States in 2014. And in the last several years, global market (value) of PARP (Poly ADP-Ribose Polymerase) Inhibitor developed rapidly, with an average growth rate of 133.8% during 2015 to 2018.
Market Analysis and Insights: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market is valued at US$ 2178 million in 2019. The market size will reach US$ 16180 million by the end of 2026, growing at a CAGR of 32.8% during 2021-2026.
Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Scope and Market Size
PARP (Poly ADP-Ribose Polymerase) Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Lynparza
Zejula
Rubraca
Talzenna
Other
Segment by Application
Ovarian Cancer
Breast Cancer
Other
By Company
AstraZeneca
Tesaro
Merck & Co
Clovis Oncology
Pfizer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
